Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues

References

• Vakili‐Ghartavol R, Mombeiny R, Salmaninejad A, et al. Tumor‐associated macrophages and epithelial–mesenchymal transition in cancer: nanotechnology comes into view. J Cell Physiol. 2018;233(12):9223–9236.
   PubMed Web of Science ®Google Scholar
• Canu IG, Schulte PA, Riediker M, et al. Methodological, political and legal issues in the assessment of the effects of nanotechnology on human health. J Epidemiol Commun Health. 2018;72(2):148–153.
   PubMed Web of Science ®Google Scholar
• Wang F, Lu C-H, Willner I. From cascaded catalytic nucleic acids to enzyme–DNA nanostructures: controlling reactivity, sensing, logic operations, and assembly of complex structures. Chem Rev. 2014;114(5):2881–2941.
   PubMed Web of Science ®Google Scholar
• Fubini B, Ghiazza M, Fenoglio I. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology. 2010;4(4):347–363.
   PubMed Web of Science ®Google Scholar
• Mosayebi J, Kiyasatfar M, Laurent S. Synthesis, functionalization, and design of magnetic nanoparticles for theranostic applications. Adv Healthcare Mater. 2017;6(23):1700306.
   Web of Science ®Google Scholar
• Ramirez-Nuñez A, Jimenez-Garcia L, Goya G, et al. In vitro magnetic hyperthermia using polyphenol-coated Fe3O4@ γFe2O3 nanoparticles from Cinnamomun verum and Vanilla planifolia: the concert of green synthesis and therapeutic possibilities. Nanotechnology. 2018;29(7):074001.
   PubMed Web of Science ®Google Scholar
• Stark WJ, Stoessel PR, Wohlleben W, et al. Industrial applications of nanoparticles. Chem Soc Rev. 2015;44(16):5793–5805.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Milani AS, Stroeve P. Synthesis, surface architecture and biological response of superparamagnetic iron oxide nanoparticles for application in drug delivery: a review. IJBNN. 2010;1(2/3/4):164–201.
   Google Scholar
• Shagholani H, Ghoreishi SM, Sharifi SH. Conversion of amine groups on chitosan-coated SPIONs into carbocyclic acid and investigation of its interaction with BSA in drug delivery systems. J Drug Deliv Sci Technol. 2018;45:373–377.
   Web of Science ®Google Scholar
• Mahmoudi M, Sant S, Wang B, et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011;63(1-2):24–46.
   PubMed Web of Science ®Google Scholar
• Mohammed L, Gomaa HG, Ragab D, et al. Magnetic nanoparticles for environmental and biomedical applications: a review. Particuology. 2017;30:1–14.
   Web of Science ®Google Scholar
• Mahmoudi M, Hofmann H, Rothen-Rutishauser B, et al. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev. 2012;112(4):2323–2338.
   PubMed Web of Science ®Google Scholar
• Nune SK, Gunda P, Thallapally PK, et al. Nanoparticles for biomedical imaging. Expert Opin Drug Deliv. 2009;6(11):1175–1194.
   PubMed Web of Science ®Google Scholar
• Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2010;62(3):284–304.
   PubMed Web of Science ®Google Scholar
• Andreas K, Georgieva R, Ladwig M, et al. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials. 2012;33(18):4515–4525.
   PubMed Web of Science ®Google Scholar
• Li L, Jiang W, Luo K, et al. Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics. 2013;3(8):595–615.
   PubMed Web of Science ®Google Scholar
• Liao S-H, Liu C-H, Bastakoti BP, et al. Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia. Int J Nanomed. 2015;10:3315–3327.
   PubMed Web of Science ®Google Scholar
• Verma J, Lal S, Van Noorden CJ. Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma. Int J Nanomed. 2014;9:2863–2877.
   PubMed Web of Science ®Google Scholar
• Laurent S, Dutz S, Häfeli UO, et al. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci. 2011;166(1–2):8–23.
   PubMed Web of Science ®Google Scholar
• Pongrac IM, Pavičić I, Milić M, et al. Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles. Int J Nanomed. 2016;11:1701–1715.
   PubMed Web of Science ®Google Scholar
• Clift MJ, Gehr P, Rothen-Rutishauser B. Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch Toxicol. 2011;85(7):723–731.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li J, Xu K, et al. Characterization of superparamagnetic iron oxide nanoparticle-induced apoptosis in PC12 cells and mouse hippocampus and striatum. Toxicol Lett. 2018;292:151–161.
   PubMed Web of Science ®Google Scholar
• Singh N, Jenkins GJ, Asadi R, et al. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1(1):5358.
   PubMedGoogle Scholar
• Møller P, Jacobsen NR, Folkmann JK, et al. Role of oxidative damage in toxicity of particulates. Free Radic Res. 2010;44(1):1–46.
   PubMed Web of Science ®Google Scholar
• Lei L, Ling-Ling J, Yun Z, et al. Toxicity of superparamagnetic iron oxide nanoparticles: research strategies and implications for nanomedicine. Chin Phys B. 2013;22(12):127503.
   Web of Science ®Google Scholar
• Laffon B, Fernández-Bertólez N, Costa C, et al. Cellular and molecular toxicity of iron oxide nanoparticles. In: Cellular and molecular toxicology of nanoparticles. Berlin (Germany): Springer; 2018. p. 199–213.
   Google Scholar
• Elias A, Tsourkas A. Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles. ASH Educ Program Book 2009;2009(1):720–726.
   Google Scholar
• Kawanishi M, Ogo S, Ikemoto M, et al. Genotoxicity and reactive oxygen species production induced by magnetite nanoparticles in mammalian cells. J Toxicol Sci. 2013;38(3):503–511.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med. 1999;340(10):764–771.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Laurent S, Shokrgozar MA, et al. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell “vision” versus physicochemical properties of nanoparticles. ACS Nano. 2011;5(9):7263–7276.
   PubMed Web of Science ®Google Scholar
• Liu WH, Liu SM, Lin SF, et al. Role of berberine in fibronectin expression via S1P2-MAPK signaling pathway in diabetic nephropathy. Chin Pharmacol Bull. 2013;29(5):723–728.
   Google Scholar
• Malvindi MA, De Matteis V, Galeone A, et al. Toxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineering. PLoS One 2014;9(1):e85835.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Simchi A, Imani M. Cytotoxicity of uncoated and polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles. J Phys Chem C. 2009;113(22):9573–9580.
   Web of Science ®Google Scholar
• Laurent S, Burtea C, Thirifays C, et al. Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications and “cell vision”. PLoS One 2012;7(1):e29997.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Saeedi-Eslami SN, Shokrgozar MA, et al. Cell “vision”: complementary factor of protein corona in nanotoxicology. Nanoscale 2012;4(17):5461–5468.
   PubMed Web of Science ®Google Scholar
• Cengelli F, Maysinger D, Tschudi-Monnet F, et al. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther. 2006;318(1):108–116.
   PubMed Web of Science ®Google Scholar
• Mbeh DA, Mireles LK, Stanicki D, et al. Human alveolar epithelial cell responses to core–shell superparamagnetic iron oxide nanoparticles (SPIONs). Langmuir 2015;31(13):3829–3839.
   PubMed Web of Science ®Google Scholar
• Ankamwar B, Lai T-C, Huang J-H, et al. Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology 2010;21(7):075102.
   PubMed Web of Science ®Google Scholar
• Karlsson HL, Cronholm P, Gustafsson J, et al. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol. 2008;21(9):1726–1732.
   PubMed Web of Science ®Google Scholar
• KöNczöL M, Ebeling S, Goldenberg E, et al. Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κB. Chem Res Toxicol. 2011;24((9):1460–1475.
   PubMed Web of Science ®Google Scholar
• Soenen SJ, De Cuyper M. Assessing cytotoxicity of (iron oxide‐based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol Imaging. 2009;4(5):207–219.
   PubMed Web of Science ®Google Scholar
• Raynal I, Prigent P, Peyramaure S, et al. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol. 2004;39(1):56–63.
   PubMed Web of Science ®Google Scholar
• Moore A, Marecos E, Bogdanov A, Jr., et al. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology. 2000;214(2):568–574.
   PubMed Web of Science ®Google Scholar
• van Landeghem FKH, Maier-Hauff K, Jordan A, et al. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials. 2009; 30(1):52–57.
   PubMed Web of Science ®Google Scholar
• Lewinski NA. Biodistribution of cadmium selenide/zinc sulfide quantum dots in aquatic organisms. Houston (TX): Rice University; 2011.
   Google Scholar
• Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small. 2008;4(1):26–49.
   PubMed Web of Science ®Google Scholar
• Sharifi S, Behzadi S, Laurent S, et al. Toxicity of nanomaterials. Chem Soc Rev. 2012;41(6):2323–2343.
   PubMed Web of Science ®Google Scholar
• Hanini A, Schmitt A, Kacem K, et al. Evaluation of iron oxide nanoparticle biocompatibility. Int J Nanomed. 2011;6:787–794.
   PubMed Web of Science ®Google Scholar
• Jain TK, Reddy MK, Morales MA, et al. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharma. 2008;5(2):316–327.
   PubMed Web of Science ®Google Scholar
• Reddy LH, Arias JL, Nicolas J, et al. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012;112(11):5818–5878.
   PubMed Web of Science ®Google Scholar
• Muldoon LL, Sàndor M, Pinkston KE, et al. Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery. 2005;57(4):785–796.
   PubMed Web of Science ®Google Scholar
• Liu SY, Han Y, Yin LP, et al. Toxicology studies of a superparamagnetic iron oxide nanoparticle in vivo. Adv Mater Res. 2008; 47–50, 1097–1100.
   Google Scholar
• Richards JM, Shaw CA, Lang NN, et al. In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. Circ Cardiovasc Imaging. 2012;5(4):509–517.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Simchi A, Imani M, et al. Superparamagnetic iron oxide nanoparticles with rigid cross-linked polyethylene glycol fumarate coating for application in imaging and drug delivery. J Phys Chem C. 2009;113(19):8124–8131.
   Web of Science ®Google Scholar
• Vadhan‐Raj S, Ford DC, Dahl NV, et al. Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: results of a phase III, open‐label, 6‐month extension study. Am J Hematol. 2016;91(2):E3–E5.
   PubMed Web of Science ®Google Scholar